浮腫治療薬の世界市場:治験レビュー

GlobalDataが発行した調査報告書(GDT20FB0071)
◆英語タイトル:Edema Global Clinical Trials Review, H2, 2019
◆商品コード:GDT20FB0071
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:195
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品およびヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥265,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥530,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD7,500 ⇒換算¥795,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Edema Global Clinical Trials Review, H2, 2019
Summary

GlobalData’s clinical trial report, “Edema Global Clinical Trials Review, H2, 2019″ provides an overview of Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Edema to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Edema to Cardiovascular Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Edema Therapeutics Clinical Trials 33
Prominent Drugs 35
Clinical Trial Profile Snapshots 36
Appendix 196
Abbreviations 196
Definitions 196
Research Methodology 197
Secondary Research 197
About GlobalData 198
Contact Us 198
Source 199

List of Tables
Edema Therapeutics, Global, Clinical Trials by Region, 2019* 7
Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11
Edema Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12
Edema Therapeutics Clinical Trials, North America, Top Countries, 2019* 13
Edema Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 14
Edema Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 15
Proportion of Edema to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 16
Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Edema to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 20
Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Edema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
Edema Therapeutics, Global, Clinical Trials by Phase, 2019* 24
Edema Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 25
Edema Therapeutics, Global, Clinical Trials by Trial Status, 2019* 27
Edema Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 30
Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 32
Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34
Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35

List of Figures
Edema Therapeutics, Global, Clinical Trials by Region (%), 2019* 7
Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8
Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11
Edema Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12
Edema Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13
Edema Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 14
Edema Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 15
Proportion of Edema to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 16
Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Edema to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 20
Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Edema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
Edema Therapeutics, Global, Clinical Trials by Phase (%), 2019* 24
Edema Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 25
Edema Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26
Edema Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 30
Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 31
Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 33
Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35
GlobalData Methodology 197

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 浮腫治療薬の世界市場:治験レビュー(Edema Global Clinical Trials Review, H2, 2019)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆